Short Interest in Edap Tms S.A. (NASDAQ:EDAP) Increases By 163.4%

Edap Tms S.A. (NASDAQ:EDAP) was the target of a significant increase in short interest during the month of December. As of December 15th, there was short interest totaling 93,243 shares, an increase of 163.4% from the November 30th total of 35,401 shares. Approximately 0.2% of the company’s stock are sold short. Based on an average daily trading volume, of 71,663 shares, the days-to-cover ratio is currently 1.3 days. Based on an average daily trading volume, of 71,663 shares, the days-to-cover ratio is currently 1.3 days. Approximately 0.2% of the company’s stock are sold short.

Hedge Funds Weigh In On Edap Tms

Hedge funds have recently bought and sold shares of the company. Banque Transatlantique SA lifted its stake in shares of Edap Tms by 7,063.7% in the 1st quarter. Banque Transatlantique SA now owns 730,699 shares of the medical equipment provider’s stock valued at $1,324,000 after purchasing an additional 720,499 shares in the last quarter. Scoggin Management LP acquired a new position in Edap Tms during the 1st quarter worth $686,000. Sage Mountain Advisors LLC bought a new stake in Edap Tms in the second quarter valued at about $165,000. Finally, Simplicity Wealth LLC bought a new stake in shares of Edap Tms in the 2nd quarter valued at approximately $54,000. 62.74% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

EDAP has been the subject of a number of research analyst reports. Weiss Ratings reissued a “sell (d-)” rating on shares of Edap Tms in a report on Monday. Jefferies Financial Group reiterated a “hold” rating and set a $2.00 price target on shares of Edap Tms in a report on Thursday, November 6th. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $8.50.

Edap Tms Stock Up 13.6%

Shares of EDAP traded up $0.41 during midday trading on Friday, reaching $3.38. The stock had a trading volume of 50,879 shares, compared to its average volume of 81,067. The company has a market cap of $126.19 million, a price-to-earnings ratio of -5.92 and a beta of -0.15. The company’s fifty day simple moving average is $2.37 and its two-hundred day simple moving average is $2.04. Edap Tms has a 1-year low of $1.21 and a 1-year high of $3.45. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.41 and a quick ratio of 0.97.

Edap Tms (NASDAQ:EDAP) last announced its quarterly earnings results on Thursday, November 6th. The medical equipment provider reported ($0.15) EPS for the quarter, topping the consensus estimate of ($0.26) by $0.11. Edap Tms had a negative net margin of 30.95% and a negative return on equity of 61.60%. The firm had revenue of $16.29 million for the quarter, compared to analyst estimates of $15.05 million. Equities research analysts expect that Edap Tms will post -0.6 earnings per share for the current year.

Edap Tms Company Profile

Edap Tms SA (NASDAQ: EDAP) is a Lyon, France–based medical device company that develops and markets noninvasive therapeutic systems for urological applications. The firm’s core focus lies in high-intensity focused ultrasound (HIFU) for localized prostate tissue ablation and extracorporeal shock-wave lithotripsy for kidney stone fragmentation. Edap Tms’s Ablatherm HIFU platform delivers targeted ultrasound energy to treat prostate cancer without incisions, while its Sonolith line offers pulse-focused shock waves designed to break down urinary calculi.

Since its founding in 1989, Edap Tms has pursued regulatory clearances in multiple markets, including CE marking in Europe and FDA clearance for its HIFU system in the United States.